• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Business/Financial News

Dexcom dips after hours on Q1 EPS miss, remains confident of U.S. G7 launch this year

April 28, 2022 By Sean Whooley

Dexcom updated logo

Dexcom (Nasdaq:DXCM) shares took a hit after hours today on first-quarter results that fell short of the consensus earnings forecast. DXCM shares were down 6.2% after hours but mostly recovered by the end of the next day. The San Diego-based company posted profits of $97.3 million, or 93¢ per share, on sales of $628.8 million […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Wall Street Beat Tagged With: Dexcom

Walmart unveils telehealth offering for managing diabetes

April 28, 2022 By Sean Whooley

Walmart Health Virtual Care Diabetes Program

Walmart announced today that its MeMD national telehealth provider partner launched the Walmart Health Virtual Care Diabetes Program. The platform, available as a standalone or as part of a comprehensive medical and behavioral telehealth program, was developed for employers and payors to help their employees and members close gaps in diabetes management among employees and […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: American Diabetes Association, Walmart

Glooko adds former Eli Lilly exec to its board of directors

April 27, 2022 By Sean Whooley

Glooko Logo

Diabetes management technology developer Glooko announced today that it appointed Alfonso “Chito” Zulueta to its board of directors. Zulueta joins Palo Alto, California-based Glooko’s board having spent more than 30 years with Eli Lilly and Company, serving as a senior executive across an array of global business and commercial units. According to a news release, […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Eli Lilly, Eli Lilly & Co., glooko, Personnel, Personnel Moves

Abbott, Camdiab, Ypsomed forge partnership for automated insulin delivery

April 27, 2022 By Sean Whooley

Abbott FreeStyle Libre 3 CamDiab Ypsomed ypsopump

Abbott (NYSE:ABT) announced today that it partnered with CamDiab and Ypsomed (SWX:YPSN) to produce an integrated automated insulin delivery (AID) system. The companies announced the partnership at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona, Spain. It seeks to develop and commercialize the integrated AID system with an initial focus centered around […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: abbott, CamDiab, Ypsomed

Insulet announces positive study data for Omnipod 5 for type 1, type 2 diabetes

April 27, 2022 By Sean Whooley

Insulet Omnipod 5 Dexcom G6

Insulet (Nasdaq:PODD) today unveiled study results for the new Omnipod 5 automated insulin delivery system in type 1 and type 2 diabetes. Acton, Massachusetts-based Insulet presented results from studies as well as user experience data for both type 1 and type 2 diabetes at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona, […]

Filed Under: Auto-injectors, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Insulet

Sweetch adds American Diabetes Association exec to its advisory board

April 26, 2022 By Sean Whooley

Sweetch

Chronic condition therapeutic developer Sweetch announced today that Dr. Robert A. Gabbay has joined the company as an advisor. Gabbay currently serves as the chief scientific and medical officer at the American Diabetes Association, leading the organization’s efforts to drive discovery in diabetes research, care and prevention. He also serves as an associate professor of […]

Filed Under: Big Data, Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Personnel, Personnel Moves, Sweetch

Impel NeuroPharma rebrands to Impel Pharmaceuticals as part of corporate transformation

April 25, 2022 By Sean Whooley

Impel Neuropharma logo updated

Impel NeuroPharma (Nasdaq:IMPL) announced today that it changed its name to Impel Pharmaceuticals as part of a corporate rebrand. Seattle-based Impel develops proprietary Precision Olfactory Delivery (POD) technology to treat patients suffering from diseases across a range of areas in addition to the central nervous system. The company’s Trudhesa nasal spray for treating migraine in […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Neurological, Otolaryngology Ear, Nose & Throat, Pharmaceuticals Tagged With: Impel NeuroPharma Inc., Impel Pharmaceuticals

EMA gives positive opinion on Novo Nordisk’s human insulin with flexible storage

April 25, 2022 By Sean Whooley

Novo Nordisk

Novo Nordisk (NYSE:NVO) announced that the European Medicines Agency (EMA) granted a positive opinion on a storage update for insulin. EMA’s positive opinion relates to a proposed update to the storage conditions of two human insulins: Actrapid (short-acting insulin) and Insulatard (intermediate-acting insulin). Bagsværd, Denmark-based Novo Nordisk said in a news release that the EMA’s […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Regulatory/Compliance Tagged With: Novo Nordisk

Comera inks deal with Intas to reformulate infusion treatments into one-shot self-injections

April 20, 2022 By Sean Whooley

Comera Intas

Comera Life Sciences announced that it will collaborate with Intas Pharmaceuticals to develop a new generation of biologic medicines. Woburn, Massachusetts-based Comera will develop a differentiated formulation of an Intas product using its SQore formulation platform, while Ahmedabad, India-based Intas will provide research funding with the option to acquire global rights to the formulation through […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured Tagged With: Comera, Intas

Koru Medical names former Fresenius Kabi VP as chief technology officer

April 19, 2022 By Sean Whooley

Koru Medical Systems

Koru Medical Systems (Nasdaq:KRMD) announced that it appointed medtech veteran Brian Case as its new chief technology officer (CTO). With more than 20 years of experience in medtech R&D, Case joins after spending more than 16 years at Fresenius Kabi as VP of R&D. Before Fresenius Kabi, he served as an R&D program manager for […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Personnel Tagged With: Koru Medical Systems, Personnel, Personnel Moves

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 86
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS